ARCHIVES

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

NIES Issue RFA For Studies On Alternative Types Of Cancer Bioassay

October 31, 1980

NIH oncology peer reviewers are protesting the outcome of a recent meeting in which their own grant applications fared so poorly that the reviewers said they were penalized for their service.

May 6, 2005

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

NCI Advisory Group, Other Cancer Meetings

November 26, 1976

Gallo Actively Searching For New Position

July 1, 1994

In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents

May 8, 1981